nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—CSK—systemic lupus erythematosus	0.208	0.443	CbGaD
Dasatinib—LYN—systemic lupus erythematosus	0.166	0.354	CbGaD
Dasatinib—BLK—systemic lupus erythematosus	0.0954	0.203	CbGaD
Dasatinib—FMO3—Dapsone—systemic lupus erythematosus	0.0697	0.31	CbGbCtD
Dasatinib—ABCG2—Leflunomide—systemic lupus erythematosus	0.0178	0.0789	CbGbCtD
Dasatinib—CYP1B1—Dexamethasone—systemic lupus erythematosus	0.0115	0.0511	CbGbCtD
Dasatinib—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.011	0.0487	CbGbCtD
Dasatinib—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0088	0.0391	CbGbCtD
Dasatinib—ABCG2—Cyclosporine—systemic lupus erythematosus	0.00831	0.0369	CbGbCtD
Dasatinib—CYP1A2—Leflunomide—systemic lupus erythematosus	0.00732	0.0325	CbGbCtD
Dasatinib—CYP3A5—Dapsone—systemic lupus erythematosus	0.00701	0.0311	CbGbCtD
Dasatinib—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.00608	0.027	CbGbCtD
Dasatinib—ABCG2—Dexamethasone—systemic lupus erythematosus	0.00547	0.0243	CbGbCtD
Dasatinib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00522	0.0232	CbGbCtD
Dasatinib—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.00505	0.0224	CbGbCtD
Dasatinib—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.00488	0.0217	CbGbCtD
Dasatinib—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00461	0.0205	CbGbCtD
Dasatinib—ABCG2—Methotrexate—systemic lupus erythematosus	0.0044	0.0195	CbGbCtD
Dasatinib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00396	0.0176	CbGbCtD
Dasatinib—ABCB1—Betamethasone—systemic lupus erythematosus	0.00339	0.0151	CbGbCtD
Dasatinib—ABCB1—Prednisolone—systemic lupus erythematosus	0.00335	0.0149	CbGbCtD
Dasatinib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00317	0.0141	CbGbCtD
Dasatinib—ABCB1—Prednisone—systemic lupus erythematosus	0.00316	0.014	CbGbCtD
Dasatinib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00313	0.0139	CbGbCtD
Dasatinib—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00303	0.0135	CbGbCtD
Dasatinib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.003	0.0133	CbGbCtD
Dasatinib—CYP3A4—Dapsone—systemic lupus erythematosus	0.00273	0.0121	CbGbCtD
Dasatinib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00237	0.0105	CbGbCtD
Dasatinib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00237	0.0105	CbGbCtD
Dasatinib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00203	0.00903	CbGbCtD
Dasatinib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00201	0.00891	CbGbCtD
Dasatinib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00197	0.00877	CbGbCtD
Dasatinib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0019	0.00845	CbGbCtD
Dasatinib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00189	0.00841	CbGbCtD
Dasatinib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0018	0.00798	CbGbCtD
Dasatinib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00159	0.00705	CbGbCtD
Dasatinib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00118	0.00525	CbGbCtD
Dasatinib—CSK—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.000721	0.334	CbGdCrCtD
Dasatinib—TESK1—tendon—systemic lupus erythematosus	0.000231	0.00311	CbGeAlD
Dasatinib—CYP3A4—urine—systemic lupus erythematosus	0.00023	0.0031	CbGeAlD
Dasatinib—MAPK14—skin of body—systemic lupus erythematosus	0.00023	0.0031	CbGeAlD
Dasatinib—EPHA2—nephron tubule—systemic lupus erythematosus	0.000229	0.00309	CbGeAlD
Dasatinib—ZAK—lung—systemic lupus erythematosus	0.000229	0.00309	CbGeAlD
Dasatinib—FYN—nephron tubule—systemic lupus erythematosus	0.000229	0.00308	CbGeAlD
Dasatinib—SIK3—nervous system—systemic lupus erythematosus	0.000228	0.00308	CbGeAlD
Dasatinib—STK36—tendon—systemic lupus erythematosus	0.000227	0.00306	CbGeAlD
Dasatinib—EPHA3—central nervous system—systemic lupus erythematosus	0.000226	0.00304	CbGeAlD
Dasatinib—CSK—lymphoid tissue—systemic lupus erythematosus	0.000225	0.00303	CbGeAlD
Dasatinib—MAP3K3—nephron tubule—systemic lupus erythematosus	0.000224	0.00301	CbGeAlD
Dasatinib—HCK—lymphoid tissue—systemic lupus erythematosus	0.000222	0.00299	CbGeAlD
Dasatinib—SIK3—central nervous system—systemic lupus erythematosus	0.00022	0.00296	CbGeAlD
Dasatinib—BMPR1B—lung—systemic lupus erythematosus	0.00022	0.00296	CbGeAlD
Dasatinib—MAP3K19—lung—systemic lupus erythematosus	0.00022	0.00296	CbGeAlD
Dasatinib—BTK—lung—systemic lupus erythematosus	0.000219	0.00295	CbGeAlD
Dasatinib—MAPK14—kidney—systemic lupus erythematosus	0.000217	0.00292	CbGeAlD
Dasatinib—JAK2—skin of body—systemic lupus erythematosus	0.000216	0.00291	CbGeAlD
Dasatinib—TNK2—lung—systemic lupus erythematosus	0.000215	0.0029	CbGeAlD
Dasatinib—FYN—skin of body—systemic lupus erythematosus	0.000213	0.00287	CbGeAlD
Dasatinib—YES1—connective tissue—systemic lupus erythematosus	0.000213	0.00287	CbGeAlD
Dasatinib—STK35—tendon—systemic lupus erythematosus	0.000213	0.00287	CbGeAlD
Dasatinib—ZAK—nervous system—systemic lupus erythematosus	0.000212	0.00286	CbGeAlD
Dasatinib—CSK—tendon—systemic lupus erythematosus	0.000211	0.00285	CbGeAlD
Dasatinib—PDGFRA—connective tissue—systemic lupus erythematosus	0.000209	0.00282	CbGeAlD
Dasatinib—HCK—tendon—systemic lupus erythematosus	0.000209	0.00281	CbGeAlD
Dasatinib—MAP3K3—skin of body—systemic lupus erythematosus	0.000208	0.00281	CbGeAlD
Dasatinib—EPHA5—nervous system—systemic lupus erythematosus	0.000208	0.0028	CbGeAlD
Dasatinib—ABL2—tendon—systemic lupus erythematosus	0.000207	0.0028	CbGeAlD
Dasatinib—LYN—nervous system—systemic lupus erythematosus	0.000207	0.00278	CbGeAlD
Dasatinib—YES1—nephron tubule—systemic lupus erythematosus	0.000207	0.00278	CbGeAlD
Dasatinib—EPHB4—kidney—systemic lupus erythematosus	0.000205	0.00277	CbGeAlD
Dasatinib—SRC—connective tissue—systemic lupus erythematosus	0.000205	0.00276	CbGeAlD
Dasatinib—CSK—bone marrow—systemic lupus erythematosus	0.000205	0.00276	CbGeAlD
Dasatinib—ZAK—central nervous system—systemic lupus erythematosus	0.000204	0.00275	CbGeAlD
Dasatinib—JAK2—kidney—systemic lupus erythematosus	0.000204	0.00275	CbGeAlD
Dasatinib—SIK1—lymphoid tissue—systemic lupus erythematosus	0.000204	0.00275	CbGeAlD
Dasatinib—BMPR1B—nervous system—systemic lupus erythematosus	0.000203	0.00274	CbGeAlD
Dasatinib—MAP3K19—nervous system—systemic lupus erythematosus	0.000203	0.00274	CbGeAlD
Dasatinib—TESK1—lung—systemic lupus erythematosus	0.000203	0.00273	CbGeAlD
Dasatinib—HCK—bone marrow—systemic lupus erythematosus	0.000202	0.00272	CbGeAlD
Dasatinib—FYN—kidney—systemic lupus erythematosus	0.000201	0.00271	CbGeAlD
Dasatinib—EPHB4—cortex of kidney—systemic lupus erythematosus	0.0002	0.0027	CbGeAlD
Dasatinib—EPHA5—central nervous system—systemic lupus erythematosus	0.0002	0.00269	CbGeAlD
Dasatinib—ERBB3—lymphoid tissue—systemic lupus erythematosus	0.0002	0.00269	CbGeAlD
Dasatinib—TNK2—nervous system—systemic lupus erythematosus	0.000199	0.00269	CbGeAlD
Dasatinib—EPHB3—lung—systemic lupus erythematosus	0.000199	0.00269	CbGeAlD
Dasatinib—STK36—lung—systemic lupus erythematosus	0.000199	0.00269	CbGeAlD
Dasatinib—EPHB6—skin of body—systemic lupus erythematosus	0.000199	0.00268	CbGeAlD
Dasatinib—LYN—central nervous system—systemic lupus erythematosus	0.000199	0.00268	CbGeAlD
Dasatinib—JAK2—cortex of kidney—systemic lupus erythematosus	0.000199	0.00268	CbGeAlD
Dasatinib—MAP3K2—lymphoid tissue—systemic lupus erythematosus	0.000198	0.00267	CbGeAlD
Dasatinib—RIPK2—tendon—systemic lupus erythematosus	0.000196	0.00264	CbGeAlD
Dasatinib—FYN—cortex of kidney—systemic lupus erythematosus	0.000196	0.00264	CbGeAlD
Dasatinib—MAP3K19—central nervous system—systemic lupus erythematosus	0.000196	0.00264	CbGeAlD
Dasatinib—BMPR1B—central nervous system—systemic lupus erythematosus	0.000196	0.00264	CbGeAlD
Dasatinib—LIMK2—lung—systemic lupus erythematosus	0.000193	0.0026	CbGeAlD
Dasatinib—TNK2—central nervous system—systemic lupus erythematosus	0.000192	0.00259	CbGeAlD
Dasatinib—SIK1—tendon—systemic lupus erythematosus	0.000192	0.00258	CbGeAlD
Dasatinib—MAP4K5—cortex of kidney—systemic lupus erythematosus	0.000191	0.00258	CbGeAlD
Dasatinib—MAP3K3—cortex of kidney—systemic lupus erythematosus	0.000191	0.00258	CbGeAlD
Dasatinib—RIPK2—bone marrow—systemic lupus erythematosus	0.00019	0.00256	CbGeAlD
Dasatinib—EPHA4—tendon—systemic lupus erythematosus	0.00019	0.00256	CbGeAlD
Dasatinib—TESK1—nervous system—systemic lupus erythematosus	0.000188	0.00253	CbGeAlD
Dasatinib—STK35—lung—systemic lupus erythematosus	0.000187	0.00252	CbGeAlD
Dasatinib—MAPK14—lymphoid tissue—systemic lupus erythematosus	0.000186	0.00251	CbGeAlD
Dasatinib—SIK1—bone marrow—systemic lupus erythematosus	0.000186	0.0025	CbGeAlD
Dasatinib—CSK—lung—systemic lupus erythematosus	0.000186	0.0025	CbGeAlD
Dasatinib—FGR—lymphoid tissue—systemic lupus erythematosus	0.000185	0.0025	CbGeAlD
Dasatinib—SRC—skin of body—systemic lupus erythematosus	0.000185	0.0025	CbGeAlD
Dasatinib—STK36—nervous system—systemic lupus erythematosus	0.000185	0.00249	CbGeAlD
Dasatinib—EPHB3—nervous system—systemic lupus erythematosus	0.000185	0.00249	CbGeAlD
Dasatinib—CSF1R—connective tissue—systemic lupus erythematosus	0.000184	0.00248	CbGeAlD
Dasatinib—HCK—lung—systemic lupus erythematosus	0.000183	0.00247	CbGeAlD
Dasatinib—EPHB6—cortex of kidney—systemic lupus erythematosus	0.000183	0.00247	CbGeAlD
Dasatinib—ABL2—lung—systemic lupus erythematosus	0.000182	0.00245	CbGeAlD
Dasatinib—YES1—kidney—systemic lupus erythematosus	0.000182	0.00245	CbGeAlD
Dasatinib—TESK1—central nervous system—systemic lupus erythematosus	0.000181	0.00243	CbGeAlD
Dasatinib—MAP3K2—bone marrow—systemic lupus erythematosus	0.00018	0.00243	CbGeAlD
Dasatinib—LIMK2—nervous system—systemic lupus erythematosus	0.000178	0.0024	CbGeAlD
Dasatinib—EPHB3—central nervous system—systemic lupus erythematosus	0.000178	0.00239	CbGeAlD
Dasatinib—STK36—central nervous system—systemic lupus erythematosus	0.000178	0.00239	CbGeAlD
Dasatinib—YES1—cortex of kidney—systemic lupus erythematosus	0.000177	0.00238	CbGeAlD
Dasatinib—JAK2—lymphoid tissue—systemic lupus erythematosus	0.000175	0.00236	CbGeAlD
Dasatinib—MAPK14—tendon—systemic lupus erythematosus	0.000175	0.00236	CbGeAlD
Dasatinib—SRC—kidney—systemic lupus erythematosus	0.000175	0.00235	CbGeAlD
Dasatinib—FGR—tendon—systemic lupus erythematosus	0.000174	0.00235	CbGeAlD
Dasatinib—EPHA2—lymphoid tissue—systemic lupus erythematosus	0.000173	0.00233	CbGeAlD
Dasatinib—STK35—nervous system—systemic lupus erythematosus	0.000173	0.00233	CbGeAlD
Dasatinib—FYN—lymphoid tissue—systemic lupus erythematosus	0.000173	0.00233	CbGeAlD
Dasatinib—RIPK2—lung—systemic lupus erythematosus	0.000172	0.00232	CbGeAlD
Dasatinib—CSK—nervous system—systemic lupus erythematosus	0.000172	0.00232	CbGeAlD
Dasatinib—LIMK2—central nervous system—systemic lupus erythematosus	0.000172	0.00232	CbGeAlD
Dasatinib—HCK—nervous system—systemic lupus erythematosus	0.00017	0.00229	CbGeAlD
Dasatinib—MAPK14—bone marrow—systemic lupus erythematosus	0.000169	0.00228	CbGeAlD
Dasatinib—MAP4K5—lymphoid tissue—systemic lupus erythematosus	0.000169	0.00227	CbGeAlD
Dasatinib—FGR—bone marrow—systemic lupus erythematosus	0.000169	0.00227	CbGeAlD
Dasatinib—LCK—bone marrow—systemic lupus erythematosus	0.000169	0.00227	CbGeAlD
Dasatinib—SIK1—lung—systemic lupus erythematosus	0.000168	0.00227	CbGeAlD
Dasatinib—KIT—connective tissue—systemic lupus erythematosus	0.000167	0.00225	CbGeAlD
Dasatinib—STK35—central nervous system—systemic lupus erythematosus	0.000167	0.00224	CbGeAlD
Dasatinib—EPHA4—lung—systemic lupus erythematosus	0.000166	0.00224	CbGeAlD
Dasatinib—CSF1R—skin of body—systemic lupus erythematosus	0.000166	0.00224	CbGeAlD
Dasatinib—CYP1A2—blood plasma—systemic lupus erythematosus	0.000166	0.00224	CbGeAlD
Dasatinib—EPHB4—tendon—systemic lupus erythematosus	0.000166	0.00223	CbGeAlD
Dasatinib—CSK—central nervous system—systemic lupus erythematosus	0.000165	0.00223	CbGeAlD
Dasatinib—ERBB3—lung—systemic lupus erythematosus	0.000165	0.00222	CbGeAlD
Dasatinib—JAK2—tendon—systemic lupus erythematosus	0.000165	0.00222	CbGeAlD
Dasatinib—PDGFRB—connective tissue—systemic lupus erythematosus	0.000163	0.0022	CbGeAlD
Dasatinib—HCK—central nervous system—systemic lupus erythematosus	0.000163	0.0022	CbGeAlD
Dasatinib—MAP3K2—lung—systemic lupus erythematosus	0.000163	0.0022	CbGeAlD
Dasatinib—EPHA2—tendon—systemic lupus erythematosus	0.000163	0.00219	CbGeAlD
Dasatinib—FYN—tendon—systemic lupus erythematosus	0.000162	0.00219	CbGeAlD
Dasatinib—KIT—nephron tubule—systemic lupus erythematosus	0.000162	0.00218	CbGeAlD
Dasatinib—EPHB4—bone marrow—systemic lupus erythematosus	0.000161	0.00216	CbGeAlD
Dasatinib—CYP3A5—blood plasma—systemic lupus erythematosus	0.00016	0.00216	CbGeAlD
Dasatinib—JAK2—bone marrow—systemic lupus erythematosus	0.000159	0.00215	CbGeAlD
Dasatinib—MAP3K3—tendon—systemic lupus erythematosus	0.000159	0.00214	CbGeAlD
Dasatinib—MAP4K5—tendon—systemic lupus erythematosus	0.000159	0.00214	CbGeAlD
Dasatinib—FYN—bone marrow—systemic lupus erythematosus	0.000157	0.00212	CbGeAlD
Dasatinib—MAP2K5—cortex of kidney—systemic lupus erythematosus	0.000156	0.00211	CbGeAlD
Dasatinib—YES1—lymphoid tissue—systemic lupus erythematosus	0.000156	0.0021	CbGeAlD
Dasatinib—SIK1—nervous system—systemic lupus erythematosus	0.000156	0.0021	CbGeAlD
Dasatinib—EPHA4—nervous system—systemic lupus erythematosus	0.000154	0.00208	CbGeAlD
Dasatinib—MAP4K5—bone marrow—systemic lupus erythematosus	0.000154	0.00207	CbGeAlD
Dasatinib—MAP3K3—bone marrow—systemic lupus erythematosus	0.000154	0.00207	CbGeAlD
Dasatinib—MAPK14—lung—systemic lupus erythematosus	0.000153	0.00207	CbGeAlD
Dasatinib—PDGFRA—lymphoid tissue—systemic lupus erythematosus	0.000153	0.00206	CbGeAlD
Dasatinib—FGR—lung—systemic lupus erythematosus	0.000153	0.00206	CbGeAlD
Dasatinib—LCK—lung—systemic lupus erythematosus	0.000153	0.00206	CbGeAlD
Dasatinib—ERBB3—nervous system—systemic lupus erythematosus	0.000153	0.00206	CbGeAlD
Dasatinib—EPHB6—tendon—systemic lupus erythematosus	0.000152	0.00204	CbGeAlD
Dasatinib—MAP3K2—nervous system—systemic lupus erythematosus	0.000151	0.00204	CbGeAlD
Dasatinib—KIT—skin of body—systemic lupus erythematosus	0.000151	0.00203	CbGeAlD
Dasatinib—SRC—lymphoid tissue—systemic lupus erythematosus	0.00015	0.00202	CbGeAlD
Dasatinib—SIK1—central nervous system—systemic lupus erythematosus	0.00015	0.00202	CbGeAlD
Dasatinib—EPHA4—central nervous system—systemic lupus erythematosus	0.000148	0.002	CbGeAlD
Dasatinib—FMO3—lung—systemic lupus erythematosus	0.000148	0.00199	CbGeAlD
Dasatinib—PDGFRB—skin of body—systemic lupus erythematosus	0.000147	0.00199	CbGeAlD
Dasatinib—ERBB3—central nervous system—systemic lupus erythematosus	0.000147	0.00198	CbGeAlD
Dasatinib—YES1—tendon—systemic lupus erythematosus	0.000147	0.00198	CbGeAlD
Dasatinib—ABL1—connective tissue—systemic lupus erythematosus	0.000146	0.00196	CbGeAlD
Dasatinib—MAP3K2—central nervous system—systemic lupus erythematosus	0.000146	0.00196	CbGeAlD
Dasatinib—EPHB4—lung—systemic lupus erythematosus	0.000146	0.00196	CbGeAlD
Dasatinib—JAK2—lung—systemic lupus erythematosus	0.000144	0.00195	CbGeAlD
Dasatinib—PDGFRA—tendon—systemic lupus erythematosus	0.000144	0.00194	CbGeAlD
Dasatinib—EPHA2—lung—systemic lupus erythematosus	0.000143	0.00192	CbGeAlD
Dasatinib—FYN—lung—systemic lupus erythematosus	0.000143	0.00192	CbGeAlD
Dasatinib—KIT—kidney—systemic lupus erythematosus	0.000142	0.00192	CbGeAlD
Dasatinib—MAPK14—nervous system—systemic lupus erythematosus	0.000142	0.00192	CbGeAlD
Dasatinib—YES1—bone marrow—systemic lupus erythematosus	0.000142	0.00191	CbGeAlD
Dasatinib—FGR—nervous system—systemic lupus erythematosus	0.000142	0.00191	CbGeAlD
Dasatinib—ABL1—nephron tubule—systemic lupus erythematosus	0.000141	0.0019	CbGeAlD
Dasatinib—MAP4K5—lung—systemic lupus erythematosus	0.000139	0.00188	CbGeAlD
Dasatinib—MAP3K3—lung—systemic lupus erythematosus	0.000139	0.00188	CbGeAlD
Dasatinib—PDGFRB—kidney—systemic lupus erythematosus	0.000139	0.00187	CbGeAlD
Dasatinib—KIT—cortex of kidney—systemic lupus erythematosus	0.000139	0.00187	CbGeAlD
Dasatinib—MAPK14—central nervous system—systemic lupus erythematosus	0.000137	0.00184	CbGeAlD
Dasatinib—FMO3—nervous system—systemic lupus erythematosus	0.000137	0.00184	CbGeAlD
Dasatinib—FGR—central nervous system—systemic lupus erythematosus	0.000136	0.00184	CbGeAlD
Dasatinib—PDGFRB—cortex of kidney—systemic lupus erythematosus	0.000135	0.00182	CbGeAlD
Dasatinib—CSF1R—lymphoid tissue—systemic lupus erythematosus	0.000135	0.00181	CbGeAlD
Dasatinib—JAK2—nervous system—systemic lupus erythematosus	0.000134	0.0018	CbGeAlD
Dasatinib—EPHB6—lung—systemic lupus erythematosus	0.000133	0.00179	CbGeAlD
Dasatinib—EPHA2—nervous system—systemic lupus erythematosus	0.000132	0.00178	CbGeAlD
Dasatinib—FYN—nervous system—systemic lupus erythematosus	0.000132	0.00178	CbGeAlD
Dasatinib—FMO3—central nervous system—systemic lupus erythematosus	0.000132	0.00177	CbGeAlD
Dasatinib—ABL1—skin of body—systemic lupus erythematosus	0.000131	0.00177	CbGeAlD
Dasatinib—MAP2K5—tendon—systemic lupus erythematosus	0.00013	0.00175	CbGeAlD
Dasatinib—MAP4K5—nervous system—systemic lupus erythematosus	0.000129	0.00174	CbGeAlD
Dasatinib—MAP3K3—nervous system—systemic lupus erythematosus	0.000129	0.00174	CbGeAlD
Dasatinib—JAK2—central nervous system—systemic lupus erythematosus	0.000129	0.00174	CbGeAlD
Dasatinib—YES1—lung—systemic lupus erythematosus	0.000129	0.00173	CbGeAlD
Dasatinib—EPHA2—central nervous system—systemic lupus erythematosus	0.000127	0.00172	CbGeAlD
Dasatinib—FYN—central nervous system—systemic lupus erythematosus	0.000127	0.00171	CbGeAlD
Dasatinib—CSF1R—tendon—systemic lupus erythematosus	0.000127	0.00171	CbGeAlD
Dasatinib—PDGFRA—lung—systemic lupus erythematosus	0.000126	0.0017	CbGeAlD
Dasatinib—MAP4K5—central nervous system—systemic lupus erythematosus	0.000124	0.00167	CbGeAlD
Dasatinib—MAP3K3—central nervous system—systemic lupus erythematosus	0.000124	0.00167	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Methylprednisolone—systemic lupus erythematosus	0.000124	0.0575	CbGdCrCtD
Dasatinib—ABL1—kidney—systemic lupus erythematosus	0.000124	0.00167	CbGeAlD
Dasatinib—SRC—lung—systemic lupus erythematosus	0.000124	0.00167	CbGeAlD
Dasatinib—CYP1B1—connective tissue—systemic lupus erythematosus	0.000123	0.00166	CbGeAlD
Dasatinib—EPHB6—nervous system—systemic lupus erythematosus	0.000123	0.00166	CbGeAlD
Dasatinib—CSF1R—bone marrow—systemic lupus erythematosus	0.000123	0.00165	CbGeAlD
Dasatinib—KIT—lymphoid tissue—systemic lupus erythematosus	0.000122	0.00165	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Betamethasone—systemic lupus erythematosus	0.000122	0.0566	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Dexamethasone—systemic lupus erythematosus	0.000122	0.0566	CbGdCrCtD
Dasatinib—ABL1—cortex of kidney—systemic lupus erythematosus	0.000121	0.00163	CbGeAlD
Dasatinib—CYP3A4—blood plasma—systemic lupus erythematosus	0.00012	0.00162	CbGeAlD
Dasatinib—CYP1B1—nephron tubule—systemic lupus erythematosus	0.000119	0.00161	CbGeAlD
Dasatinib—PDGFRB—lymphoid tissue—systemic lupus erythematosus	0.000119	0.00161	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Triamcinolone—systemic lupus erythematosus	0.000119	0.0553	CbGdCrCtD
Dasatinib—YES1—nervous system—systemic lupus erythematosus	0.000119	0.00161	CbGeAlD
Dasatinib—EPHB6—central nervous system—systemic lupus erythematosus	0.000119	0.0016	CbGeAlD
Dasatinib—PDGFRA—nervous system—systemic lupus erythematosus	0.000117	0.00157	CbGeAlD
Dasatinib—YES1—central nervous system—systemic lupus erythematosus	0.000115	0.00155	CbGeAlD
Dasatinib—SRC—nervous system—systemic lupus erythematosus	0.000115	0.00154	CbGeAlD
Dasatinib—MAP2K5—lung—systemic lupus erythematosus	0.000114	0.00153	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Prednisone—systemic lupus erythematosus	0.000113	0.0525	CbGdCrCtD
Dasatinib—PDGFRA—central nervous system—systemic lupus erythematosus	0.000112	0.00152	CbGeAlD
Dasatinib—PDGFRB—tendon—systemic lupus erythematosus	0.000112	0.00151	CbGeAlD
Dasatinib—KIT—bone marrow—systemic lupus erythematosus	0.000111	0.0015	CbGeAlD
Dasatinib—CYP1B1—skin of body—systemic lupus erythematosus	0.000111	0.0015	CbGeAlD
Dasatinib—CSF1R—lung—systemic lupus erythematosus	0.000111	0.0015	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Prednisolone—systemic lupus erythematosus	0.000111	0.0512	CbGdCrCtD
Dasatinib—SRC—central nervous system—systemic lupus erythematosus	0.00011	0.00149	CbGeAlD
Dasatinib—PDGFRB—bone marrow—systemic lupus erythematosus	0.000109	0.00147	CbGeAlD
Dasatinib—ABL1—lymphoid tissue—systemic lupus erythematosus	0.000106	0.00143	CbGeAlD
Dasatinib—MAP2K5—nervous system—systemic lupus erythematosus	0.000105	0.00142	CbGeAlD
Dasatinib—CYP1B1—kidney—systemic lupus erythematosus	0.000105	0.00141	CbGeAlD
Dasatinib—CSF1R—nervous system—systemic lupus erythematosus	0.000103	0.00139	CbGeAlD
Dasatinib—CYP1B1—cortex of kidney—systemic lupus erythematosus	0.000102	0.00138	CbGeAlD
Dasatinib—MAP2K5—central nervous system—systemic lupus erythematosus	0.000101	0.00137	CbGeAlD
Dasatinib—KIT—lung—systemic lupus erythematosus	0.000101	0.00136	CbGeAlD
Dasatinib—ABL1—tendon—systemic lupus erythematosus	0.0001	0.00135	CbGeAlD
Dasatinib—CSF1R—central nervous system—systemic lupus erythematosus	9.9e-05	0.00133	CbGeAlD
Dasatinib—PDGFRB—lung—systemic lupus erythematosus	9.85e-05	0.00133	CbGeAlD
Dasatinib—ABL1—bone marrow—systemic lupus erythematosus	9.69e-05	0.00131	CbGeAlD
Dasatinib—KIT—nervous system—systemic lupus erythematosus	9.34e-05	0.00126	CbGeAlD
Dasatinib—PDGFRB—nervous system—systemic lupus erythematosus	9.12e-05	0.00123	CbGeAlD
Dasatinib—CYP1B1—lymphoid tissue—systemic lupus erythematosus	9.01e-05	0.00121	CbGeAlD
Dasatinib—KIT—central nervous system—systemic lupus erythematosus	8.99e-05	0.00121	CbGeAlD
Dasatinib—ABCG2—nephron tubule—systemic lupus erythematosus	8.89e-05	0.0012	CbGeAlD
Dasatinib—PDGFRB—central nervous system—systemic lupus erythematosus	8.78e-05	0.00118	CbGeAlD
Dasatinib—ABL1—lung—systemic lupus erythematosus	8.78e-05	0.00118	CbGeAlD
Dasatinib—ABCB1—blood plasma—systemic lupus erythematosus	8.5e-05	0.00115	CbGeAlD
Dasatinib—CYP1B1—tendon—systemic lupus erythematosus	8.47e-05	0.00114	CbGeAlD
Dasatinib—CYP3A5—nephron tubule—systemic lupus erythematosus	8.25e-05	0.00111	CbGeAlD
Dasatinib—ABL1—nervous system—systemic lupus erythematosus	8.13e-05	0.0011	CbGeAlD
Dasatinib—CYP1A1—skin of body—systemic lupus erythematosus	7.87e-05	0.00106	CbGeAlD
Dasatinib—ABL1—central nervous system—systemic lupus erythematosus	7.83e-05	0.00105	CbGeAlD
Dasatinib—PKMYT1—Danazol—Hydrocortisone—systemic lupus erythematosus	7.46e-05	0.0346	CbGdCrCtD
Dasatinib—CYP1B1—lung—systemic lupus erythematosus	7.44e-05	0.001	CbGeAlD
Dasatinib—CYP1A1—kidney—systemic lupus erythematosus	7.42e-05	0.001	CbGeAlD
Dasatinib—CYP3A5—kidney—systemic lupus erythematosus	7.25e-05	0.000978	CbGeAlD
Dasatinib—CYP3A5—cortex of kidney—systemic lupus erythematosus	7.06e-05	0.000952	CbGeAlD
Dasatinib—CYP1B1—nervous system—systemic lupus erythematosus	6.89e-05	0.000928	CbGeAlD
Dasatinib—CYP1B1—central nervous system—systemic lupus erythematosus	6.63e-05	0.000893	CbGeAlD
Dasatinib—PKMYT1—Danazol—Prednisone—systemic lupus erythematosus	6.43e-05	0.0298	CbGdCrCtD
Dasatinib—ABCG2—bone marrow—systemic lupus erythematosus	6.11e-05	0.000824	CbGeAlD
Dasatinib—ABCG2—lung—systemic lupus erythematosus	5.54e-05	0.000746	CbGeAlD
Dasatinib—CYP3A4—kidney—systemic lupus erythematosus	5.44e-05	0.000734	CbGeAlD
Dasatinib—TESK1—Betamethasone—Hydrocortisone—systemic lupus erythematosus	5.35e-05	0.0248	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	5.35e-05	0.0248	CbGdCrCtD
Dasatinib—CYP1A2—lung—systemic lupus erythematosus	5.33e-05	0.000718	CbGeAlD
Dasatinib—CYP1A1—lung—systemic lupus erythematosus	5.26e-05	0.000708	CbGeAlD
Dasatinib—CYP3A5—lung—systemic lupus erythematosus	5.14e-05	0.000693	CbGeAlD
Dasatinib—TESK1—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	5.04e-05	0.0234	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Methylprednisolone—systemic lupus erythematosus	5.04e-05	0.0234	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Betamethasone—systemic lupus erythematosus	4.96e-05	0.023	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Dexamethasone—systemic lupus erythematosus	4.96e-05	0.023	CbGdCrCtD
Dasatinib—CYP1A1—nervous system—systemic lupus erythematosus	4.87e-05	0.000656	CbGeAlD
Dasatinib—TESK1—Betamethasone—Triamcinolone—systemic lupus erythematosus	4.85e-05	0.0225	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Triamcinolone—systemic lupus erythematosus	4.85e-05	0.0225	CbGdCrCtD
Dasatinib—CYP1A1—central nervous system—systemic lupus erythematosus	4.69e-05	0.000632	CbGeAlD
Dasatinib—TESK1—Dexamethasone—Prednisone—systemic lupus erythematosus	4.6e-05	0.0213	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisone—systemic lupus erythematosus	4.6e-05	0.0213	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisolone—systemic lupus erythematosus	4.49e-05	0.0208	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisolone—systemic lupus erythematosus	4.49e-05	0.0208	CbGdCrCtD
Dasatinib—ABCB1—nephron tubule—systemic lupus erythematosus	4.38e-05	0.000591	CbGeAlD
Dasatinib—ABCB1—kidney—systemic lupus erythematosus	3.85e-05	0.000519	CbGeAlD
Dasatinib—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	3.77e-05	0.00039	CcSEcCtD
Dasatinib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	3.76e-05	0.000389	CcSEcCtD
Dasatinib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	3.75e-05	0.000388	CcSEcCtD
Dasatinib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	3.75e-05	0.000388	CcSEcCtD
Dasatinib—ABCB1—cortex of kidney—systemic lupus erythematosus	3.75e-05	0.000506	CbGeAlD
Dasatinib—Nausea—Leflunomide—systemic lupus erythematosus	3.75e-05	0.000388	CcSEcCtD
Dasatinib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000387	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	3.73e-05	0.000386	CcSEcCtD
Dasatinib—Fatigue—Hydrocortisone—systemic lupus erythematosus	3.73e-05	0.000386	CcSEcCtD
Dasatinib—Vision blurred—Prednisone—systemic lupus erythematosus	3.72e-05	0.000384	CcSEcCtD
Dasatinib—Urethral disorder—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000384	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	3.71e-05	0.000384	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	3.7e-05	0.000383	CcSEcCtD
Dasatinib—Pain—Hydrocortisone—systemic lupus erythematosus	3.7e-05	0.000383	CcSEcCtD
Dasatinib—Oedema—Betamethasone—systemic lupus erythematosus	3.7e-05	0.000382	CcSEcCtD
Dasatinib—Oedema—Dexamethasone—systemic lupus erythematosus	3.7e-05	0.000382	CcSEcCtD
Dasatinib—Insomnia—Triamcinolone—systemic lupus erythematosus	3.68e-05	0.000381	CcSEcCtD
Dasatinib—Insomnia—Methylprednisolone—systemic lupus erythematosus	3.68e-05	0.00038	CcSEcCtD
Dasatinib—Infection—Betamethasone—systemic lupus erythematosus	3.67e-05	0.00038	CcSEcCtD
Dasatinib—Infection—Dexamethasone—systemic lupus erythematosus	3.67e-05	0.00038	CcSEcCtD
Dasatinib—Ill-defined disorder—Prednisone—systemic lupus erythematosus	3.66e-05	0.000379	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisolone—systemic lupus erythematosus	3.65e-05	0.000378	CcSEcCtD
Dasatinib—Visual impairment—Methotrexate—systemic lupus erythematosus	3.65e-05	0.000377	CcSEcCtD
Dasatinib—Anaemia—Prednisone—systemic lupus erythematosus	3.64e-05	0.000377	CcSEcCtD
Dasatinib—Shock—Betamethasone—systemic lupus erythematosus	3.64e-05	0.000376	CcSEcCtD
Dasatinib—Shock—Dexamethasone—systemic lupus erythematosus	3.64e-05	0.000376	CcSEcCtD
Dasatinib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	3.63e-05	0.000376	CcSEcCtD
Dasatinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	3.62e-05	0.000375	CcSEcCtD
Dasatinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	3.62e-05	0.000375	CcSEcCtD
Dasatinib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	3.62e-05	0.000374	CcSEcCtD
Dasatinib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	3.62e-05	0.000374	CcSEcCtD
Dasatinib—Tachycardia—Dexamethasone—systemic lupus erythematosus	3.61e-05	0.000373	CcSEcCtD
Dasatinib—Tachycardia—Betamethasone—systemic lupus erythematosus	3.61e-05	0.000373	CcSEcCtD
Dasatinib—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	3.59e-05	0.000371	CcSEcCtD
Dasatinib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	3.59e-05	0.000371	CcSEcCtD
Dasatinib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.58e-05	0.00037	CcSEcCtD
Dasatinib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	3.58e-05	0.00037	CcSEcCtD
Dasatinib—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	3.57e-05	0.00037	CcSEcCtD
Dasatinib—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	3.57e-05	0.00037	CcSEcCtD
Dasatinib—CYP3A4—nervous system—systemic lupus erythematosus	3.57e-05	0.000481	CbGeAlD
Dasatinib—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	3.56e-05	0.000369	CcSEcCtD
Dasatinib—Malaise—Prednisone—systemic lupus erythematosus	3.56e-05	0.000368	CcSEcCtD
Dasatinib—Vertigo—Prednisone—systemic lupus erythematosus	3.54e-05	0.000367	CcSEcCtD
Dasatinib—Eye disorder—Methotrexate—systemic lupus erythematosus	3.54e-05	0.000366	CcSEcCtD
Dasatinib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.54e-05	0.000366	CcSEcCtD
Dasatinib—Syncope—Prednisone—systemic lupus erythematosus	3.54e-05	0.000366	CcSEcCtD
Dasatinib—Tinnitus—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000365	CcSEcCtD
Dasatinib—Anorexia—Dexamethasone—systemic lupus erythematosus	3.52e-05	0.000364	CcSEcCtD
Dasatinib—Anorexia—Betamethasone—systemic lupus erythematosus	3.52e-05	0.000364	CcSEcCtD
Dasatinib—Urticaria—Prednisolone—systemic lupus erythematosus	3.52e-05	0.000364	CcSEcCtD
Dasatinib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	3.51e-05	0.000363	CcSEcCtD
Dasatinib—Fatigue—Triamcinolone—systemic lupus erythematosus	3.51e-05	0.000363	CcSEcCtD
Dasatinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.5e-05	0.000362	CcSEcCtD
Dasatinib—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	3.5e-05	0.000362	CcSEcCtD
Dasatinib—Asthenia—Cyclosporine—systemic lupus erythematosus	3.49e-05	0.000361	CcSEcCtD
Dasatinib—Pain—Triamcinolone—systemic lupus erythematosus	3.48e-05	0.00036	CcSEcCtD
Dasatinib—Loss of consciousness—Prednisone—systemic lupus erythematosus	3.47e-05	0.000359	CcSEcCtD
Dasatinib—Hypotension—Dexamethasone—systemic lupus erythematosus	3.45e-05	0.000357	CcSEcCtD
Dasatinib—Hypotension—Betamethasone—systemic lupus erythematosus	3.45e-05	0.000357	CcSEcCtD
Dasatinib—Pruritus—Cyclosporine—systemic lupus erythematosus	3.44e-05	0.000356	CcSEcCtD
Dasatinib—CYP3A4—central nervous system—systemic lupus erythematosus	3.44e-05	0.000463	CbGeAlD
Dasatinib—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.44e-05	0.000355	CcSEcCtD
Dasatinib—Angiopathy—Methotrexate—systemic lupus erythematosus	3.43e-05	0.000355	CcSEcCtD
Dasatinib—Immune system disorder—Methotrexate—systemic lupus erythematosus	3.42e-05	0.000354	CcSEcCtD
Dasatinib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.42e-05	0.000354	CcSEcCtD
Dasatinib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.42e-05	0.000354	CcSEcCtD
Dasatinib—Convulsion—Prednisone—systemic lupus erythematosus	3.42e-05	0.000353	CcSEcCtD
Dasatinib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	3.41e-05	0.000353	CcSEcCtD
Dasatinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.41e-05	0.000352	CcSEcCtD
Dasatinib—Hypertension—Prednisone—systemic lupus erythematosus	3.4e-05	0.000352	CcSEcCtD
Dasatinib—Chills—Methotrexate—systemic lupus erythematosus	3.4e-05	0.000351	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.37e-05	0.000348	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.37e-05	0.000348	CcSEcCtD
Dasatinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.36e-05	0.000348	CcSEcCtD
Dasatinib—Arthralgia—Prednisone—systemic lupus erythematosus	3.36e-05	0.000347	CcSEcCtD
Dasatinib—Myalgia—Prednisone—systemic lupus erythematosus	3.36e-05	0.000347	CcSEcCtD
Dasatinib—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	3.36e-05	0.000347	CcSEcCtD
Dasatinib—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	3.35e-05	0.000346	CcSEcCtD
Dasatinib—Anxiety—Prednisone—systemic lupus erythematosus	3.35e-05	0.000346	CcSEcCtD
Dasatinib—Alopecia—Methotrexate—systemic lupus erythematosus	3.35e-05	0.000346	CcSEcCtD
Dasatinib—Insomnia—Dexamethasone—systemic lupus erythematosus	3.34e-05	0.000346	CcSEcCtD
Dasatinib—Insomnia—Betamethasone—systemic lupus erythematosus	3.34e-05	0.000346	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	3.33e-05	0.000345	CcSEcCtD
Dasatinib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.33e-05	0.000345	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.32e-05	0.000344	CcSEcCtD
Dasatinib—Discomfort—Prednisone—systemic lupus erythematosus	3.32e-05	0.000343	CcSEcCtD
Dasatinib—Mental disorder—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000343	CcSEcCtD
Dasatinib—ABCB1—lymphoid tissue—systemic lupus erythematosus	3.31e-05	0.000446	CbGeAlD
Dasatinib—Erythema—Methotrexate—systemic lupus erythematosus	3.3e-05	0.000341	CcSEcCtD
Dasatinib—Malnutrition—Methotrexate—systemic lupus erythematosus	3.3e-05	0.000341	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.26e-05	0.000338	CcSEcCtD
Dasatinib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.25e-05	0.000337	CcSEcCtD
Dasatinib—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.25e-05	0.000337	CcSEcCtD
Dasatinib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.25e-05	0.000336	CcSEcCtD
Dasatinib—Urticaria—Triamcinolone—systemic lupus erythematosus	3.24e-05	0.000335	CcSEcCtD
Dasatinib—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.23e-05	0.000334	CcSEcCtD
Dasatinib—Dysgeusia—Methotrexate—systemic lupus erythematosus	3.23e-05	0.000334	CcSEcCtD
Dasatinib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.22e-05	0.000333	CcSEcCtD
Dasatinib—Dizziness—Cyclosporine—systemic lupus erythematosus	3.22e-05	0.000333	CcSEcCtD
Dasatinib—Oedema—Prednisone—systemic lupus erythematosus	3.22e-05	0.000333	CcSEcCtD
Dasatinib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.21e-05	0.000332	CcSEcCtD
Dasatinib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.000332	CcSEcCtD
Dasatinib—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.21e-05	0.000332	CcSEcCtD
Dasatinib—Infection—Prednisone—systemic lupus erythematosus	3.2e-05	0.000331	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.19e-05	0.00033	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.19e-05	0.00033	CcSEcCtD
Dasatinib—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.19e-05	0.00033	CcSEcCtD
Dasatinib—Fatigue—Betamethasone—systemic lupus erythematosus	3.19e-05	0.00033	CcSEcCtD
Dasatinib—Fatigue—Dexamethasone—systemic lupus erythematosus	3.19e-05	0.00033	CcSEcCtD
Dasatinib—Shock—Prednisone—systemic lupus erythematosus	3.17e-05	0.000328	CcSEcCtD
Dasatinib—Pain—Dexamethasone—systemic lupus erythematosus	3.16e-05	0.000327	CcSEcCtD
Dasatinib—Pain—Betamethasone—systemic lupus erythematosus	3.16e-05	0.000327	CcSEcCtD
Dasatinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.16e-05	0.000327	CcSEcCtD
Dasatinib—Tachycardia—Prednisone—systemic lupus erythematosus	3.14e-05	0.000325	CcSEcCtD
Dasatinib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.14e-05	0.000325	CcSEcCtD
Dasatinib—Skin disorder—Prednisone—systemic lupus erythematosus	3.13e-05	0.000323	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.11e-05	0.000322	CcSEcCtD
Dasatinib—Vision blurred—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000321	CcSEcCtD
Dasatinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.1e-05	0.000321	CcSEcCtD
Dasatinib—Vomiting—Cyclosporine—systemic lupus erythematosus	3.09e-05	0.00032	CcSEcCtD
Dasatinib—Rash—Cyclosporine—systemic lupus erythematosus	3.07e-05	0.000317	CcSEcCtD
Dasatinib—Anorexia—Prednisone—systemic lupus erythematosus	3.07e-05	0.000317	CcSEcCtD
Dasatinib—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.07e-05	0.000317	CcSEcCtD
Dasatinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.06e-05	0.000317	CcSEcCtD
Dasatinib—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000316	CcSEcCtD
Dasatinib—Headache—Cyclosporine—systemic lupus erythematosus	3.05e-05	0.000315	CcSEcCtD
Dasatinib—Anaemia—Methotrexate—systemic lupus erythematosus	3.05e-05	0.000315	CcSEcCtD
Dasatinib—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.05e-05	0.000315	CcSEcCtD
Dasatinib—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.05e-05	0.000315	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.02e-05	0.000313	CcSEcCtD
Dasatinib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.02e-05	0.000313	CcSEcCtD
Dasatinib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.02e-05	0.000312	CcSEcCtD
Dasatinib—ABCB1—bone marrow—systemic lupus erythematosus	3.01e-05	0.000406	CbGeAlD
Dasatinib—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3e-05	0.00031	CcSEcCtD
Dasatinib—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	2.99e-05	0.00031	CcSEcCtD
Dasatinib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.99e-05	0.00031	CcSEcCtD
Dasatinib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.99e-05	0.000309	CcSEcCtD
Dasatinib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.97e-05	0.000308	CcSEcCtD
Dasatinib—Malaise—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000307	CcSEcCtD
Dasatinib—Vertigo—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000306	CcSEcCtD
Dasatinib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.96e-05	0.000306	CcSEcCtD
Dasatinib—Urticaria—Dexamethasone—systemic lupus erythematosus	2.94e-05	0.000304	CcSEcCtD
Dasatinib—Urticaria—Betamethasone—systemic lupus erythematosus	2.94e-05	0.000304	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.93e-05	0.000303	CcSEcCtD
Dasatinib—Dizziness—Prednisolone—systemic lupus erythematosus	2.93e-05	0.000303	CcSEcCtD
Dasatinib—Asthenia—Triamcinolone—systemic lupus erythematosus	2.92e-05	0.000302	CcSEcCtD
Dasatinib—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.92e-05	0.000302	CcSEcCtD
Dasatinib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.92e-05	0.000302	CcSEcCtD
Dasatinib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	2.92e-05	0.000302	CcSEcCtD
Dasatinib—Body temperature increased—Betamethasone—systemic lupus erythematosus	2.92e-05	0.000302	CcSEcCtD
Dasatinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	2.92e-05	0.000302	CcSEcCtD
Dasatinib—Insomnia—Prednisone—systemic lupus erythematosus	2.91e-05	0.000301	CcSEcCtD
Dasatinib—Nausea—Cyclosporine—systemic lupus erythematosus	2.89e-05	0.000299	CcSEcCtD
Dasatinib—Pruritus—Triamcinolone—systemic lupus erythematosus	2.88e-05	0.000298	CcSEcCtD
Dasatinib—Cough—Methotrexate—systemic lupus erythematosus	2.88e-05	0.000298	CcSEcCtD
Dasatinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.88e-05	0.000297	CcSEcCtD
Dasatinib—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.86e-05	0.000296	CcSEcCtD
Dasatinib—Convulsion—Methotrexate—systemic lupus erythematosus	2.86e-05	0.000295	CcSEcCtD
Dasatinib—Dyspepsia—Prednisone—systemic lupus erythematosus	2.83e-05	0.000293	CcSEcCtD
Dasatinib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.82e-05	0.000292	CcSEcCtD
Dasatinib—Arthralgia—Methotrexate—systemic lupus erythematosus	2.81e-05	0.00029	CcSEcCtD
Dasatinib—Chest pain—Methotrexate—systemic lupus erythematosus	2.81e-05	0.00029	CcSEcCtD
Dasatinib—Myalgia—Methotrexate—systemic lupus erythematosus	2.81e-05	0.00029	CcSEcCtD
Dasatinib—Decreased appetite—Prednisone—systemic lupus erythematosus	2.8e-05	0.000289	CcSEcCtD
Dasatinib—Rash—Prednisolone—systemic lupus erythematosus	2.79e-05	0.000289	CcSEcCtD
Dasatinib—Dermatitis—Prednisolone—systemic lupus erythematosus	2.79e-05	0.000289	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.79e-05	0.000288	CcSEcCtD
Dasatinib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.78e-05	0.000288	CcSEcCtD
Dasatinib—Fatigue—Prednisone—systemic lupus erythematosus	2.77e-05	0.000287	CcSEcCtD
Dasatinib—Headache—Prednisolone—systemic lupus erythematosus	2.77e-05	0.000287	CcSEcCtD
Dasatinib—Discomfort—Methotrexate—systemic lupus erythematosus	2.77e-05	0.000287	CcSEcCtD
Dasatinib—Constipation—Prednisone—systemic lupus erythematosus	2.75e-05	0.000285	CcSEcCtD
Dasatinib—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.75e-05	0.000285	CcSEcCtD
Dasatinib—ABCB1—lung—systemic lupus erythematosus	2.73e-05	0.000368	CbGeAlD
Dasatinib—Rash—Hydrocortisone—systemic lupus erythematosus	2.73e-05	0.000282	CcSEcCtD
Dasatinib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.72e-05	0.000282	CcSEcCtD
Dasatinib—Confusional state—Methotrexate—systemic lupus erythematosus	2.71e-05	0.000281	CcSEcCtD
Dasatinib—Headache—Hydrocortisone—systemic lupus erythematosus	2.71e-05	0.00028	CcSEcCtD
Dasatinib—Dizziness—Triamcinolone—systemic lupus erythematosus	2.69e-05	0.000279	CcSEcCtD
Dasatinib—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.69e-05	0.000278	CcSEcCtD
Dasatinib—Infection—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000276	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.65e-05	0.000274	CcSEcCtD
Dasatinib—Asthenia—Betamethasone—systemic lupus erythematosus	2.65e-05	0.000274	CcSEcCtD
Dasatinib—Asthenia—Dexamethasone—systemic lupus erythematosus	2.65e-05	0.000274	CcSEcCtD
Dasatinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.64e-05	0.000273	CcSEcCtD
Dasatinib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.63e-05	0.000272	CcSEcCtD
Dasatinib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.63e-05	0.000272	CcSEcCtD
Dasatinib—Nausea—Prednisolone—systemic lupus erythematosus	2.63e-05	0.000272	CcSEcCtD
Dasatinib—Pruritus—Dexamethasone—systemic lupus erythematosus	2.61e-05	0.00027	CcSEcCtD
Dasatinib—Pruritus—Betamethasone—systemic lupus erythematosus	2.61e-05	0.00027	CcSEcCtD
Dasatinib—Skin disorder—Methotrexate—systemic lupus erythematosus	2.61e-05	0.00027	CcSEcCtD
Dasatinib—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.6e-05	0.000269	CcSEcCtD
Dasatinib—Vomiting—Triamcinolone—systemic lupus erythematosus	2.59e-05	0.000268	CcSEcCtD
Dasatinib—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.58e-05	0.000267	CcSEcCtD
Dasatinib—Nausea—Hydrocortisone—systemic lupus erythematosus	2.57e-05	0.000266	CcSEcCtD
Dasatinib—Rash—Triamcinolone—systemic lupus erythematosus	2.57e-05	0.000266	CcSEcCtD
Dasatinib—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.57e-05	0.000265	CcSEcCtD
Dasatinib—Anorexia—Methotrexate—systemic lupus erythematosus	2.56e-05	0.000265	CcSEcCtD
Dasatinib—Rash—Methylprednisolone—systemic lupus erythematosus	2.56e-05	0.000265	CcSEcCtD
Dasatinib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.56e-05	0.000265	CcSEcCtD
Dasatinib—Urticaria—Prednisone—systemic lupus erythematosus	2.56e-05	0.000265	CcSEcCtD
Dasatinib—Headache—Triamcinolone—systemic lupus erythematosus	2.55e-05	0.000264	CcSEcCtD
Dasatinib—Headache—Methylprednisolone—systemic lupus erythematosus	2.55e-05	0.000263	CcSEcCtD
Dasatinib—Abdominal pain—Prednisone—systemic lupus erythematosus	2.54e-05	0.000263	CcSEcCtD
Dasatinib—Body temperature increased—Prednisone—systemic lupus erythematosus	2.54e-05	0.000263	CcSEcCtD
Dasatinib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.53e-05	0.000262	CcSEcCtD
Dasatinib—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.53e-05	0.000262	CcSEcCtD
Dasatinib—ABCB1—nervous system—systemic lupus erythematosus	2.53e-05	0.000341	CbGeAlD
Dasatinib—Hypotension—Methotrexate—systemic lupus erythematosus	2.51e-05	0.00026	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.45e-05	0.000254	CcSEcCtD
Dasatinib—Dizziness—Dexamethasone—systemic lupus erythematosus	2.44e-05	0.000253	CcSEcCtD
Dasatinib—Dizziness—Betamethasone—systemic lupus erythematosus	2.44e-05	0.000253	CcSEcCtD
Dasatinib—ABCB1—central nervous system—systemic lupus erythematosus	2.43e-05	0.000328	CbGeAlD
Dasatinib—Insomnia—Methotrexate—systemic lupus erythematosus	2.43e-05	0.000252	CcSEcCtD
Dasatinib—Nausea—Triamcinolone—systemic lupus erythematosus	2.42e-05	0.00025	CcSEcCtD
Dasatinib—Nausea—Methylprednisolone—systemic lupus erythematosus	2.41e-05	0.00025	CcSEcCtD
Dasatinib—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000248	CcSEcCtD
Dasatinib—Somnolence—Methotrexate—systemic lupus erythematosus	2.39e-05	0.000247	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.37e-05	0.000245	CcSEcCtD
Dasatinib—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.37e-05	0.000245	CcSEcCtD
Dasatinib—Vomiting—Dexamethasone—systemic lupus erythematosus	2.35e-05	0.000243	CcSEcCtD
Dasatinib—Vomiting—Betamethasone—systemic lupus erythematosus	2.35e-05	0.000243	CcSEcCtD
Dasatinib—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000242	CcSEcCtD
Dasatinib—Rash—Betamethasone—systemic lupus erythematosus	2.33e-05	0.000241	CcSEcCtD
Dasatinib—Rash—Dexamethasone—systemic lupus erythematosus	2.33e-05	0.000241	CcSEcCtD
Dasatinib—Dermatitis—Betamethasone—systemic lupus erythematosus	2.33e-05	0.000241	CcSEcCtD
Dasatinib—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.33e-05	0.000241	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.32e-05	0.00024	CcSEcCtD
Dasatinib—Fatigue—Methotrexate—systemic lupus erythematosus	2.32e-05	0.00024	CcSEcCtD
Dasatinib—Headache—Dexamethasone—systemic lupus erythematosus	2.32e-05	0.00024	CcSEcCtD
Dasatinib—Headache—Betamethasone—systemic lupus erythematosus	2.32e-05	0.00024	CcSEcCtD
Dasatinib—Asthenia—Prednisone—systemic lupus erythematosus	2.31e-05	0.000239	CcSEcCtD
Dasatinib—Pain—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000238	CcSEcCtD
Dasatinib—Pruritus—Prednisone—systemic lupus erythematosus	2.28e-05	0.000236	CcSEcCtD
Dasatinib—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000229	CcSEcCtD
Dasatinib—Diarrhoea—Prednisone—systemic lupus erythematosus	2.2e-05	0.000228	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000228	CcSEcCtD
Dasatinib—Nausea—Betamethasone—systemic lupus erythematosus	2.2e-05	0.000227	CcSEcCtD
Dasatinib—Nausea—Dexamethasone—systemic lupus erythematosus	2.2e-05	0.000227	CcSEcCtD
Dasatinib—Urticaria—Methotrexate—systemic lupus erythematosus	2.14e-05	0.000221	CcSEcCtD
Dasatinib—Dizziness—Prednisone—systemic lupus erythematosus	2.13e-05	0.00022	CcSEcCtD
Dasatinib—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.13e-05	0.00022	CcSEcCtD
Dasatinib—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.13e-05	0.00022	CcSEcCtD
Dasatinib—Vomiting—Prednisone—systemic lupus erythematosus	2.05e-05	0.000212	CcSEcCtD
Dasatinib—Rash—Prednisone—systemic lupus erythematosus	2.03e-05	0.00021	CcSEcCtD
Dasatinib—Dermatitis—Prednisone—systemic lupus erythematosus	2.03e-05	0.00021	CcSEcCtD
Dasatinib—Headache—Prednisone—systemic lupus erythematosus	2.02e-05	0.000209	CcSEcCtD
Dasatinib—Hypersensitivity—Methotrexate—systemic lupus erythematosus	1.98e-05	0.000205	CcSEcCtD
Dasatinib—Asthenia—Methotrexate—systemic lupus erythematosus	1.93e-05	0.0002	CcSEcCtD
Dasatinib—Nausea—Prednisone—systemic lupus erythematosus	1.91e-05	0.000198	CcSEcCtD
Dasatinib—Pruritus—Methotrexate—systemic lupus erythematosus	1.9e-05	0.000197	CcSEcCtD
Dasatinib—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.84e-05	0.00019	CcSEcCtD
Dasatinib—Dizziness—Methotrexate—systemic lupus erythematosus	1.78e-05	0.000184	CcSEcCtD
Dasatinib—Vomiting—Methotrexate—systemic lupus erythematosus	1.71e-05	0.000177	CcSEcCtD
Dasatinib—Rash—Methotrexate—systemic lupus erythematosus	1.7e-05	0.000175	CcSEcCtD
Dasatinib—Dermatitis—Methotrexate—systemic lupus erythematosus	1.69e-05	0.000175	CcSEcCtD
Dasatinib—Headache—Methotrexate—systemic lupus erythematosus	1.69e-05	0.000174	CcSEcCtD
Dasatinib—Nausea—Methotrexate—systemic lupus erythematosus	1.6e-05	0.000165	CcSEcCtD
Dasatinib—LYN—Signaling Pathways—CD80—systemic lupus erythematosus	8.82e-07	6.66e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—EP300—systemic lupus erythematosus	8.81e-07	6.65e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCR5—systemic lupus erythematosus	8.79e-07	6.63e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—EP300—systemic lupus erythematosus	8.78e-07	6.63e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NOS3—systemic lupus erythematosus	8.75e-07	6.61e-06	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IL6—systemic lupus erythematosus	8.73e-07	6.59e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—F2—systemic lupus erythematosus	8.72e-07	6.58e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TYK2—systemic lupus erythematosus	8.71e-07	6.58e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CD80—systemic lupus erythematosus	8.68e-07	6.55e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.66e-07	6.54e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	8.65e-07	6.53e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—F2—systemic lupus erythematosus	8.61e-07	6.5e-06	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL6—systemic lupus erythematosus	8.6e-07	6.49e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—EP300—systemic lupus erythematosus	8.6e-07	6.49e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—C3—systemic lupus erythematosus	8.59e-07	6.48e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CDKN1A—systemic lupus erythematosus	8.56e-07	6.46e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—EP300—systemic lupus erythematosus	8.56e-07	6.46e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—NOS3—systemic lupus erythematosus	8.55e-07	6.46e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD4—systemic lupus erythematosus	8.53e-07	6.44e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CDKN1A—systemic lupus erythematosus	8.52e-07	6.43e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—EP300—systemic lupus erythematosus	8.49e-07	6.41e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.49e-07	6.41e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—EP300—systemic lupus erythematosus	8.46e-07	6.39e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—CDKN1B—systemic lupus erythematosus	8.46e-07	6.38e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CDKN1A—systemic lupus erythematosus	8.46e-07	6.38e-06	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL6—systemic lupus erythematosus	8.45e-07	6.38e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TYK2—systemic lupus erythematosus	8.44e-07	6.37e-06	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.37e-07	6.32e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.37e-07	6.32e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCL2—systemic lupus erythematosus	8.37e-07	6.32e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CD80—systemic lupus erythematosus	8.36e-07	6.31e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—TYK2—systemic lupus erythematosus	8.35e-07	6.31e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.34e-07	6.3e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL2—systemic lupus erythematosus	8.31e-07	6.27e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NOS3—systemic lupus erythematosus	8.28e-07	6.25e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—TGFB1—systemic lupus erythematosus	8.26e-07	6.24e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CD80—systemic lupus erythematosus	8.25e-07	6.23e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—CDKN1A—systemic lupus erythematosus	8.21e-07	6.2e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—JAK1—systemic lupus erythematosus	8.21e-07	6.2e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCL2—systemic lupus erythematosus	8.2e-07	6.19e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—EP300—systemic lupus erythematosus	8.15e-07	6.15e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—EP300—systemic lupus erythematosus	8.11e-07	6.12e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCL2—systemic lupus erythematosus	8.07e-07	6.09e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	8.07e-07	6.09e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—EP300—systemic lupus erythematosus	8.05e-07	6.07e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.04e-07	6.07e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—CDKN1B—systemic lupus erythematosus	8.02e-07	6.06e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.02e-07	6.06e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ALB—systemic lupus erythematosus	7.97e-07	6.02e-06	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—systemic lupus erythematosus	7.94e-07	6e-06	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—systemic lupus erythematosus	7.94e-07	6e-06	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—systemic lupus erythematosus	7.92e-07	5.98e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—CD4—systemic lupus erythematosus	7.88e-07	5.95e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP9—systemic lupus erythematosus	7.86e-07	5.93e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—systemic lupus erythematosus	7.85e-07	5.93e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.83e-07	5.91e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—systemic lupus erythematosus	7.82e-07	5.9e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TGFB1—systemic lupus erythematosus	7.82e-07	5.9e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—systemic lupus erythematosus	7.82e-07	5.9e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.82e-07	5.9e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—EP300—systemic lupus erythematosus	7.81e-07	5.9e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—CDKN1A—systemic lupus erythematosus	7.81e-07	5.89e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCR5—systemic lupus erythematosus	7.78e-07	5.87e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL2—systemic lupus erythematosus	7.77e-07	5.87e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TYK2—systemic lupus erythematosus	7.71e-07	5.82e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL2—systemic lupus erythematosus	7.67e-07	5.79e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.67e-07	5.79e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.66e-07	5.78e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NOS3—systemic lupus erythematosus	7.63e-07	5.76e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TYK2—systemic lupus erythematosus	7.6e-07	5.74e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—C3—systemic lupus erythematosus	7.6e-07	5.74e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	7.59e-07	5.73e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.58e-07	5.72e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS3—systemic lupus erythematosus	7.57e-07	5.71e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD4—systemic lupus erythematosus	7.56e-07	5.7e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—systemic lupus erythematosus	7.55e-07	5.7e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—F2—systemic lupus erythematosus	7.54e-07	5.69e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NOS3—systemic lupus erythematosus	7.46e-07	5.63e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—EP300—systemic lupus erythematosus	7.45e-07	5.63e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TYK2—systemic lupus erythematosus	7.44e-07	5.62e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—EP300—systemic lupus erythematosus	7.43e-07	5.61e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—systemic lupus erythematosus	7.42e-07	5.6e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—CDKN1B—systemic lupus erythematosus	7.41e-07	5.59e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—CDKN1A—systemic lupus erythematosus	7.41e-07	5.59e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.38e-07	5.57e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TYK2—systemic lupus erythematosus	7.33e-07	5.53e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NOS3—systemic lupus erythematosus	7.31e-07	5.51e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—systemic lupus erythematosus	7.25e-07	5.47e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CD80—systemic lupus erythematosus	7.23e-07	5.46e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NOS3—systemic lupus erythematosus	7.19e-07	5.43e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.18e-07	5.42e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—CDKN1B—systemic lupus erythematosus	7.1e-07	5.36e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.06e-07	5.33e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TYK2—systemic lupus erythematosus	7.06e-07	5.33e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—systemic lupus erythematosus	7.05e-07	5.32e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—EP300—systemic lupus erythematosus	7.05e-07	5.32e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.03e-07	5.31e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—systemic lupus erythematosus	7.02e-07	5.3e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP9—systemic lupus erythematosus	7.02e-07	5.3e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—systemic lupus erythematosus	7.02e-07	5.3e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7e-07	5.28e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—CD4—systemic lupus erythematosus	6.98e-07	5.27e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—systemic lupus erythematosus	6.98e-07	5.26e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TYK2—systemic lupus erythematosus	6.97e-07	5.26e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—systemic lupus erythematosus	6.95e-07	5.25e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	6.94e-07	5.24e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NOS3—systemic lupus erythematosus	6.93e-07	5.23e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—systemic lupus erythematosus	6.92e-07	5.23e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	6.91e-07	5.21e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NOS3—systemic lupus erythematosus	6.84e-07	5.16e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—CDKN1A—systemic lupus erythematosus	6.84e-07	5.16e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—systemic lupus erythematosus	6.79e-07	5.13e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—systemic lupus erythematosus	6.74e-07	5.09e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL2—systemic lupus erythematosus	6.72e-07	5.07e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—F2—systemic lupus erythematosus	6.67e-07	5.04e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—EP300—systemic lupus erythematosus	6.66e-07	5.02e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP9—systemic lupus erythematosus	6.65e-07	5.02e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.62e-07	5e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—CDKN1B—systemic lupus erythematosus	6.56e-07	4.95e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—CDKN1A—systemic lupus erythematosus	6.56e-07	4.95e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—EP300—systemic lupus erythematosus	6.51e-07	4.91e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.48e-07	4.89e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.46e-07	4.88e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—systemic lupus erythematosus	6.46e-07	4.87e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CD80—systemic lupus erythematosus	6.4e-07	4.83e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—systemic lupus erythematosus	6.38e-07	4.82e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	6.35e-07	4.79e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.33e-07	4.78e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—systemic lupus erythematosus	6.33e-07	4.78e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—systemic lupus erythematosus	6.31e-07	4.76e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.3e-07	4.76e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—EP300—systemic lupus erythematosus	6.3e-07	4.76e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—EP300—systemic lupus erythematosus	6.24e-07	4.71e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.23e-07	4.7e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—systemic lupus erythematosus	6.23e-07	4.7e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—systemic lupus erythematosus	6.19e-07	4.68e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.15e-07	4.64e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TYK2—systemic lupus erythematosus	6.1e-07	4.61e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—systemic lupus erythematosus	6.1e-07	4.6e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—CDKN1A—systemic lupus erythematosus	6.05e-07	4.57e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6e-07	4.53e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOS3—systemic lupus erythematosus	5.99e-07	4.52e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—systemic lupus erythematosus	5.99e-07	4.52e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.97e-07	4.5e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.97e-07	4.5e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—systemic lupus erythematosus	5.95e-07	4.49e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.92e-07	4.47e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—systemic lupus erythematosus	5.89e-07	4.45e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—systemic lupus erythematosus	5.87e-07	4.43e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—systemic lupus erythematosus	5.86e-07	4.42e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.84e-07	4.41e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—EP300—systemic lupus erythematosus	5.8e-07	4.38e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—systemic lupus erythematosus	5.8e-07	4.38e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.79e-07	4.37e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	5.78e-07	4.36e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—systemic lupus erythematosus	5.77e-07	4.36e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—systemic lupus erythematosus	5.77e-07	4.36e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—systemic lupus erythematosus	5.77e-07	4.35e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—EP300—systemic lupus erythematosus	5.76e-07	4.35e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—systemic lupus erythematosus	5.75e-07	4.34e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.75e-07	4.34e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—EP300—systemic lupus erythematosus	5.68e-07	4.28e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—systemic lupus erythematosus	5.66e-07	4.27e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—systemic lupus erythematosus	5.63e-07	4.25e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—systemic lupus erythematosus	5.61e-07	4.23e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—systemic lupus erythematosus	5.56e-07	4.2e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—EP300—systemic lupus erythematosus	5.56e-07	4.2e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—systemic lupus erythematosus	5.56e-07	4.19e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—systemic lupus erythematosus	5.54e-07	4.18e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.54e-07	4.18e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	5.51e-07	4.16e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—systemic lupus erythematosus	5.49e-07	4.14e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.48e-07	4.13e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—EP300—systemic lupus erythematosus	5.47e-07	4.13e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.47e-07	4.13e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	5.46e-07	4.12e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TYK2—systemic lupus erythematosus	5.4e-07	4.08e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.38e-07	4.06e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—systemic lupus erythematosus	5.34e-07	4.03e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—systemic lupus erythematosus	5.31e-07	4.01e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—systemic lupus erythematosus	5.3e-07	4e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—EP300—systemic lupus erythematosus	5.28e-07	3.98e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—systemic lupus erythematosus	5.27e-07	3.98e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—EP300—systemic lupus erythematosus	5.27e-07	3.98e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.26e-07	3.97e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—EP300—systemic lupus erythematosus	5.2e-07	3.93e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	5.2e-07	3.92e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.19e-07	3.92e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.18e-07	3.91e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—systemic lupus erythematosus	5.12e-07	3.86e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.12e-07	3.86e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—systemic lupus erythematosus	5.08e-07	3.83e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—systemic lupus erythematosus	5.01e-07	3.78e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.99e-07	3.77e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	4.97e-07	3.75e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.93e-07	3.72e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.93e-07	3.72e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	4.91e-07	3.71e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—systemic lupus erythematosus	4.88e-07	3.69e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—systemic lupus erythematosus	4.87e-07	3.67e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.83e-07	3.65e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—systemic lupus erythematosus	4.81e-07	3.63e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.79e-07	3.61e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.76e-07	3.59e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	4.7e-07	3.55e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—systemic lupus erythematosus	4.62e-07	3.48e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.59e-07	3.47e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.58e-07	3.46e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—EP300—systemic lupus erythematosus	4.56e-07	3.44e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	4.55e-07	3.43e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.52e-07	3.41e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—systemic lupus erythematosus	4.49e-07	3.39e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	4.36e-07	3.29e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—systemic lupus erythematosus	4.36e-07	3.29e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.31e-07	3.26e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	4.3e-07	3.24e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—systemic lupus erythematosus	4.26e-07	3.22e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.26e-07	3.21e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—systemic lupus erythematosus	4.25e-07	3.21e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.24e-07	3.2e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—systemic lupus erythematosus	4.13e-07	3.12e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—systemic lupus erythematosus	4.09e-07	3.08e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—EP300—systemic lupus erythematosus	4.03e-07	3.04e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.96e-07	2.99e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.92e-07	2.96e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.82e-07	2.88e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	3.78e-07	2.85e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—systemic lupus erythematosus	3.77e-07	2.85e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.75e-07	2.83e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—systemic lupus erythematosus	3.72e-07	2.81e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—systemic lupus erythematosus	3.64e-07	2.75e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—systemic lupus erythematosus	3.58e-07	2.71e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	3.57e-07	2.7e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.51e-07	2.65e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	3.48e-07	2.63e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—systemic lupus erythematosus	3.45e-07	2.61e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	3.43e-07	2.59e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—systemic lupus erythematosus	3.41e-07	2.57e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	3.13e-07	2.36e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.99e-07	2.26e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—systemic lupus erythematosus	2.98e-07	2.25e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.85e-07	2.15e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.74e-07	2.07e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.69e-07	2.03e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—systemic lupus erythematosus	2.64e-07	1.99e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.42e-07	1.82e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.31e-07	1.74e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.28e-07	1.72e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.11e-07	1.6e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.76e-07	1.33e-06	CbGpPWpGaD
